
What Is Biomarker Testing for Lung Cancer?
Biomarker testing is the evaluation of samples of a patient’s tumor, blood, or both to identify the genetic mutations responsible for the development of cancer,
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Lymphedema is a side effect of certain cancer treatments. Though uncommon, it is painful and can impact a person’s quality of life if allowed to progress. Fortunately, prompt medical intervention can reduce symptoms before they become serious. Regional Cancer Care Associates (RCCA) is one of the nation’s largest networks of oncology specialists, providing care at more than 20 locations near you in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area. Here, we present key information patients should know about lymphedema and its treatment.
The lymphatic system is a part of the body’s immune system. Its role is to maintain balanced fluid levels throughout the body. It also helps to combat infection. The system has three primary components:
When lymph vessels or nodes become damaged, lymph fluid has nowhere to go. The fluid becomes trapped in surrounding tissues. The resulting swelling is known as lymphedema.
There are two types of lymphedema: primary and secondary. Primary lymphedema is a rare genetic condition that causes underdeveloped lymph vessels. The malformed vessels lack the capacity to transport lymph fluid effectively. Primary lymphedema is rare, affecting only 1 in 100,000 people.
Secondary lymphedema is more common, affecting 1 in 1,000 people. This condition is caused by damage to lymph vessels or nodes. In some cases, the damage is caused by a cancerous tumor that forms in a lymph node. In others, overproduction of white blood cells due to leukemia may cause an obstruction. More frequently, however, lymphedema is a consequence of cancer treatment:
While treatment for any type of cancer may cause lymphedema, the highest risk occurs when the cancer is located close to lymph nodes. This includes melanoma and cancers of the breast, head and neck, bladder, ovaries, cervix, penis, and prostate.
Lymphedema is not always easy to detect. Symptoms appear only when fluid buildup reaches a critical point, which may occur months or years after treatment. Symptoms can emerge slowly or suddenly. Where they appear depends on the treatment site. Though most common in the arms or legs, symptoms of lymphedema can also affect the neck, face, mouth, abdomen, and groin. They include:
Patients should not hesitate to contact their oncologist about any of these symptoms. Swelling can be a sign of cancer returning or of lymphedema. In either case, early diagnosis gives patients the best chance at successful treatment or effective symptom management.
Like cancer and many other diseases, lymphedema is categorized in stages. This system helps physicians describe how serious the condition is, which is a key factor in planning treatment.
Stage 2 lymphedema does not generally respond well to treatment, and it carries an increased risk for skin and other infections. Stage 3 typically is permanent. For these reasons, it is best to seek care during the early stages, when treatment has the best chance of preventing serious complications.
While there is no cure for lymphedema, medical treatment can relieve symptoms and control its progress. Patients can work with a certified lymphedema therapist (CLT) to develop a management plan, which may include:
Depending on the nature and severity of lymphedema, a physician may also prescribe antibiotics to prevent secondary infections.
Because lymphedema cannot be cured, prevention is critical. Patients can take several steps to reduce their risk of lymphedema after cancer treatment, including:
Finally, patients should seek medical attention if their skin feels hot to the touch or appears red or swollen. Lymphedema management is easiest and least uncomfortable in the condition’s early stages.
Patient awareness and prompt assessment and intervention are key to avoiding serious complications from lymphedema. People can learn more about this condition at Regional Cancer Care Associates. We are one of the nation’s largest cancer care networks, with locations near you in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area. Contact us today to learn more about cancer treatments and lymphedema.
What is lymphedema?
Lymphedema is a condition characterized by swelling in the arms, legs, and other parts of the body, caused by the buildup of lymph fluid in tissue.
What cancer treatments cause lymphedema?
Surgical removal of lymph nodes can sometimes cause lymphedema by interrupting the normal flow of lymph fluid. Radiation therapy is also a frequent cause of lymphedema because it can damage lymph vessels.
Can lymphedema be prevented?
Lymphedema cannot always be prevented. By taking the right steps, however, patients can keep symptoms from becoming worse.
Can lymphedema be cured?
Lymphedema cannot be cured once it develops. If it is caught early, symptoms can be managed with elevation, compression, exercise, and skincare.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Biomarker testing is the evaluation of samples of a patient’s tumor, blood, or both to identify the genetic mutations responsible for the development of cancer,

Medical research has made tremendous strides in improving how oncologists understand and treat cancer. One of the most exciting developments is the use of radiopharmaceuticals.

Prostate cancer is a common and fairly complex disease. Though it typically grows very slowly, there are times when prostate cancer can develop suddenly and
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.